請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/53173完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 何佳安 | |
| dc.contributor.author | Yi-Qi Huang | en |
| dc.contributor.author | 黃意琪 | zh_TW |
| dc.date.accessioned | 2021-06-15T16:48:53Z | - |
| dc.date.available | 2020-08-01 | |
| dc.date.copyright | 2015-08-31 | |
| dc.date.issued | 2015 | |
| dc.date.submitted | 2015-08-07 | |
| dc.identifier.citation | (1) Herbst, R. S.; Heymach, J. V.; Lippman, S. M. 'Lung cancer,' N. Engl. J. Med. 2008, 359, 1367-1380. (2) Hirsch, F. R.; Franklin, W. A.; Gazdar, A. F.; Bunn, P. A. 'Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology,' Clin. Cancer Res. 2001, 7, 5-22. (3) Ganti, A. K.; Mulshine, J. L. 'Lung cancer screening,' Oncologist 2006, 11, 481-487. (4) Mountain, C. F. 'REvisions in the international system for staging lung cancer,' Chest 1997, 111, 1710-1717. (5) Antoinette J. Wozniak, M.; Gadgeel, S. M. 'Adjuvant treatment of non-small-cell lung cancer: How do we improve the cure rates further?,' Oncol. 2007, 21, 163-171. (6) Ando, S.; Suzuki, M.; Yamamoto, N.; Iida, T.; Kimura, H. 'The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer,' Anticancer Res. 2004, 24, 1941-1946. (7) Eddy, D. M. 'Screening for lung cancer,' Ann. Intern. Med. 1989, 111, 232-237. (8) Henschke, C. I.; Naidich, D. P.; Yankelevitz, D. F.; McGuinness, G.; McCauley, D. I.; Smith, J. P.; Libby, D.; Pasmantier, M.; Vazquez, M.; Koizumi, J.; Flieder, D.; Altorki, N.; Miettinen, O. S. 'Early lung cancer action project,' Cancer 2001, 92, 153-159. (9) Diederich, S.; Semik, M.; Lentschig, M. G.; Winter, F.; Scheld, H. H.; Roos, N.; Bongartz, G. 'Helical CT of pulmonary nodules in patients with extrathoracic malignancy: CT-surgical correlation,' Am. J. Roentgenol. 1999, 172, 353-360. (10) Xing, X. Z.; Gao, Y. N.; Zhang, D. C. 'Early diagnosis of lung cancer,' Chin. J. cancer 2003, 22, 221-223. (11) Hurst, J. H.; Hooks, S. B. 'Regulator of G-protein signaling (RGS) proteins in cancer biology,' Biochem. Pharmacol. 2009, 78, 1289-1297. (12) Tuteja, N. 'Signaling through G protein coupled receptors,' Plant Signal. Behav. 2009, 4, 942-947. (13) Posner, B. A.; Mukhopadhyay, S.; Tesmer, J. J.; Gilman, A. G.; Ross, E. M. 'Modulation of the affinity and selectivity of RGS protein interaction with G alpha subunits by a conserved asparagine/serine residue,' Biochemistry 1999, 38, 7773-7779. (14) Lee, E. K.; Ye, Y.; Kamat, A. M.; Wu, X. 'Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer,' Cancer 2013, 119, 1643-1651. (15) Snow, B. E.; Krumins, A. M.; Brothers, G. M.; Lee, S.-F.; Wall, M. A.; Chung, S.; Mangion, J.; Arya, S.; Gilman, A. G.; Siderovski, D. P. 'A G protein γ subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gβ5 subunits,' Proc. Natl. Acad. Sci. 1998, 95, 13307-13312. (16) Hurst, J. H.; Mendpara, N.; Hooks, S. B. 'Regulator of G-protein signalling expression and function in ovarian cancer cell lines,' Cell. Mol. Biol. Lett. 2009, 14, 153-174. (17) Grunebach, F.; Erndt, S.; Hantschel, M.; Heine, A.; Brossart, P. 'Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells,' Cancer Immunol. Immunother. 2008, 57, 1483-1491. (18) Rangel, J.; Nosrati, M.; Leong, S. P.; Haqq, C.; Miller, J. R., 3rd; Sagebiel, R. W.; Kashani-Sabet, M. 'Novel role for RGS1 in melanoma progression,' Am. J. Surg. Pathol. 2008, 32, 1207-1212. (19) Furuya, M.; Nishiyama, M.; Kimura, S.; Suyama, T.; Naya, Y.; Ito, H.; Nikaido, T.; Ishikura, H. 'Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma,' J. Pathol. 2004, 203, 551-558. (20) Rae, F. K.; Stephenson, S. A.; Nicol, D. L.; Clements, J. A. 'Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display,' Int. J. Cancer 2000, 88, 726-732. (21) Han, J. I.; Huang, N. N.; Kim, D. U.; Kehrl, J. H. 'RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization,' J. Leukoc. Biol. 2006, 79, 1357-1368. (22) Islam, T. C.; Asplund, A. C.; Lindvall, J. M.; Nygren, L.; Liden, J.; Kimby, E.; Christensson, B.; Smith, C. I.; Sander, B. 'High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma,' Leukemia 2003, 17, 1880-1890. (23) Tsai, C. C.; Huang, K. W.; Chen, H. F.; Zhan, B. W.; Lai, Y. H.; Lee, F. H.; Lin, C. Y.; Ho, Y. C.; Chao, Y. W.; Su, Y. C.; Jane, S. W.; Chen, Y. C.; Hsu, C. I.; Li, P. H.; Hsu, H. C.; Suzuki, Y.; Sugano, S.; Lin, J. Y. 'Gene expression analysis of human hepatocellular carcinoma by using full-length cDNA library,' J. Biomed. Sci. 2006, 13, 241-249. (24) Chen, X.; Higgins, J.; Cheung, S. T.; Li, R.; Mason, V.; Montgomery, K.; Fan, S. T.; van de Rijn, M.; So, S. 'Novel endothelial cell markers in hepatocellular carcinoma,' Mod. Pathol. 2004, 17, 1198-1210. (25) Silva, A. P.; Salim, A. C.; Bulgarelli, A.; de Souza, J. E.; Osorio, E.; Caballero, O. L.; Iseli, C.; Stevenson, B. J.; Jongeneel, C. V.; de Souza, S. J.; Simpson, A. J.; Camargo, A. A. 'Identification of 9 novel transcripts and two RGSL genes within the hereditary prostate cancer region (HPC1) at 1q25,' Gene 2003, 310, 49-57. (26) Sood, R.; Bonner, T. I.; Makalowska, I.; Stephan, D. A.; Robbins, C. M.; Connors, T. D.; Morgenbesser, S. D.; Su, K.; Faruque, M. U.; Pinkett, H.; Graham, C.; Baxevanis, A. D.; Klinger, K. W.; Landes, G. M.; Trent, J. M.; Carpten, J. D. 'Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus,' Genomics 2001, 73, 211-222. (27) Wiechec, E.; Overgaard, J.; Hansen, L. L. 'A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas,' Genes chromosomes Cancer 2008, 47, 766-780. (28) Smalley, M. J.; Iravani, M.; Leao, M.; Grigoriadis, A.; Kendrick, H.; Dexter, T.; Fenwick, K.; Regan, J. L.; Britt, K.; McDonald, S.; Lord, C. J.; Mackay, A.; Ashworth, A. 'Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers,' Breast Cancer Res. 2007, 9, R85. (29) Nikolova, D. N.; Zembutsu, H.; Sechanov, T.; Vidinov, K.; Kee, L. S.; Ivanova, R.; Becheva, E.; Kocova, M.; Toncheva, D.; Nakamura, Y. 'Genome-wide gene expression profiles of thyroid carcinoma: Identification of molecular targets for treatment of thyroid carcinoma,' Oncol. Rep. 2008, 20, 105-121. (30) Tonjes, A.; Miedlich, S.; Holzapfel, H. P.; Eszlinger, M.; Arkenau, C.; Paschke, R. 'Expression of regulators of g protein signaling mRNA is differentially regulated in hot and cold thyroid nodules,' Thyroid 2004, 14, 896-901. (31) Hamzah, J.; Jugold, M.; Kiessling, F.; Rigby, P.; Manzur, M.; Marti, H. H.; Rabie, T.; Kaden, S.; Grone, H. J.; Hammerling, G. J.; Arnold, B.; Ganss, R. 'Vascular normalization in Rgs5-deficient tumours promotes immune destruction,' Nature 2008, 453, 410-414. (32) Schwable, J.; Choudhary, C.; Thiede, C.; Tickenbrock, L.; Sargin, B.; Steur, C.; Rehage, M.; Rudat, A.; Brandts, C.; Berdel, W. E.; Muller-Tidow, C.; Serve, H. 'RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation,' Blood 2005, 105, 2107-2114. (33) Koga, H.; Imada, K.; Ueda, M.; Hishizawa, M.; Uchiyama, T. 'Identification of differentially expressed molecules in adult T-cell leukemia cells proliferating in vivo,' Cancer Sci. 2004, 95, 411-417. (34) Tatenhorst, L.; Senner, V.; Puttmann, S.; Paulus, W. 'Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility,' J. Neuropathol. Exp. Neurol. 2004, 63, 210-222. (35) Martinez-Cardus, A.; Martinez-Balibrea, E.; Bandres, E.; Malumbres, R.; Gines, A.; Manzano, J. L.; Taron, M.; Garcia-Foncillas, J.; Abad, A. 'Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer,' Mol. Cancer. Ther. 2009, 8, 194-202. (36) 柯秀幸. 分子選殖RGS11基因及探討其在肺癌中所扮演之角色. 臺北醫學大學, 台北市, 2010. (37) James, M. A.; Lu, Y.; Liu, Y.; Vikis, H. G.; You, M. 'RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway,' Cancer Res. 2009, 69, 2108-2116. (38) Feigin, M. E.; Malbon, C. C. 'RGS19 regulates Wnt-beta-catenin signaling through inactivation of Galpha(o),' J. Cell Sci. 2007, 120, 3404-3414. (39) Kirikoshi, H.; Katoh, M. 'Expression of human GIPC1 in normal tissues, cancer cell lines, and primary tumors,' Int. J. Mol. Med. 2002, 9, 509-513. (40) Riker, A. I.; Enkemann, S. A.; Fodstad, O.; Liu, S.; Ren, S.; Morris, C.; Xi, Y.; Howell, P.; Metge, B.; Samant, R. S.; Shevde, L. A.; Li, W.; Eschrich, S.; Daud, A.; Ju, J.; Matta, J. 'The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis,' BMC Med. Genomics 2008, 1, 1-13. (41) Wong, Y. F.; Cheung, T. H.; Tsao, G. S.; Lo, K. W.; Yim, S. F.; Wang, V. W.; Heung, M. M.; Chan, S. C.; Chan, L. K.; Ho, T. W.; Wong, K. W.; Li, C.; Guo, Y.; Chung, T. K.; Smith, D. I. 'Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray,' Int. J. Cancer 2006, 118, 2461-2469. (42) Zhu, Y.; Hollmen, J.; Raty, R.; Aalto, Y.; Nagy, B.; Elonen, E.; Kere, J.; Mannila, H.; Franssila, K.; Knuutila, S. 'Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma,' Br. J. Haematol. 2002, 119, 905-915. (43) Kannangai, R.; Vivekanandan, P.; Martinez-Murillo, F.; Choti, M.; Torbenson, M. 'Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways,' Human pathology 2007, 38, 639-644. (44) Cao, X.; Qin, J.; Xie, Y.; Khan, O.; Dowd, F.; Scofield, M.; Lin, M. F.; Tu, Y. 'Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells,' Oncogene 2006, 25, 3719-3734. (45) Ooe, A.; Kato, K.; Noguchi, S. 'Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers,' Breast Cancer Res. Treat. 2007, 101, 305-315. (46) Takahashi, H.; Nemoto, T.; Yoshida, T.; Honda, H.; Hasegawa, T. 'Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method,' BMC bioinformatics 2006, 7, 399. (47) Boss, C. N.; Grunebach, F.; Brauer, K.; Hantschel, M.; Mirakaj, V.; Weinschenk, T.; Stevanovic, S.; Rammensee, H. G.; Brossart, P. 'Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen,' Clin. Cancer. Res. 2007, 13, 3347-3355. (48) Chng, W. J.; Remstein, E. D.; Fonseca, R.; Bergsagel, P. L.; Vrana, J. A.; Kurtin, P. J.; Dogan, A. 'Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications,' Blood 2009, 113, 635-645. (49) Davidsson, J.; Andersson, A.; Paulsson, K.; Heidenblad, M.; Isaksson, M.; Borg, A.; Heldrup, J.; Behrendtz, M.; Panagopoulos, I.; Fioretos, T.; Johansson, B. 'Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3,' Hum. Mol. Genet. 2007, 16, 2215-2225. (50) Fevre-Montange, M.; Champier, J.; Szathmari, A.; Wierinckx, A.; Mottolese, C.; Guyotat, J.; Figarella-Branger, D.; Jouvet, A.; Lachuer, J. 'Microarray analysis reveals differential gene expression patterns in tumors of the pineal region,' J. Neuropathol. Exp. Neurol. 2006, 65, 675-684. (51) Buckbinder, L.; Velasco-Miguel, S.; Chen, Y.; Xu, N.; Talbott, R.; Gelbert, L.; Gao, J.; Seizinger, B. R.; Gutkind, J. S.; Kley, N. 'The p53 tumor suppressor targets a novel regulator of G protein signaling,' Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 7868-7872. (52) Berman, D. M.; Wang, Y.; Liu, Z.; Dong, Q.; Burke, L. A.; Liotta, L. A.; Fisher, R.; Wu, X. 'A functional polymorphism in RGS6 modulates the risk of bladder cancer,' Cancer Res. 2004, 64, 6820-6836. (53) Pan, K. F.; Liu, W. G.; Zhang, L.; You, W. C.; Lu, Y. Y. 'Mutations in components of the Wnt signaling pathway in gastric cancer,' World J. Gastroenterol. 2008, 14, 1570-1574. (54) Ishizaki, Y.; Ikeda, S.; Fujimori, M.; Shimizu, Y.; Kurihara, T.; Itamoto, T.; Kikuchi, A.; Okajima, M.; Asahara, T. 'Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas,' Int. J. Oncol. 2004, 24, 1077-1083. (55) Tokumoto, N.; Ikeda, S.; Ishizaki, Y.; Kurihara, T.; Ozaki, S.; Iseki, M.; Shimizu, Y.; Itamoto, T.; Arihiro, K.; Okajima, M.; Asahara, T. 'Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas,' Int. J. Oncol. 2005, 27, 973-980. (56) Daa, T.; Kashima, K.; Kaku, N.; Suzuki, M.; Yokoyama, S. 'Mutations in components of the Wnt signaling pathway in adenoid cystic carcinoma,' Mod. Pathol. 2004, 17, 1475-1482. (57) Baeza, N.; Masuoka, J.; Kleihues, P.; Ohgaki, H. 'AXIN1 mutations but not deletions in cerebellar medulloblastomas,' Oncogene 2003, 22, 632-636. (58) Iwai, S.; Katagiri, W.; Kong, C.; Amekawa, S.; Nakazawa, M.; Yura, Y. 'Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma,' J. Cancer Res. Clin. Oncol. 2005, 131, 773-782. (59) Jin, L. H.; Shao, Q. J.; Luo, W.; Ye, Z. Y.; Li, Q.; Lin, S. C. 'Detection of point mutations of the Axin1 gene in colorectal cancers,' Int. J. Cancer. 2003, 107, 696-699. (60) Pospisil, H.; Herrmann, A.; Butherus, K.; Pirson, S.; Reich, J. G.; Kemmner, W. 'Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression,' BMC genomics 2006, 7, 148. (61) Xu, H. T.; Wang, L.; Lin, D.; Liu, Y.; Liu, N.; Yuan, X. M.; Wang, E. H. 'Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer,' Am. J. Clin. Pathol. 2006, 125, 534-541. (62) Steg, A.; Wang, W.; Blanquicett, C.; Grunda, J. M.; Eltoum, I. A.; Wang, K.; Buchsbaum, D. J.; Vickers, S. M.; Russo, S.; Diasio, R. B.; Frost, A. R.; LoBuglio, A. F.; Grizzle, W. E.; Johnson, M. R. 'Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma,' J. Mol. Diagn. 2006, 8, 76-83. (63) Roh, M. S.; Hong, S. H.; Jeong, J. S.; Kwon, H. C.; Kim, M. C.; Cho, S. H.; Yoon, J. H.; Hwang, T. H. 'Gene expression profiling of breast cancers with emphasis of beta-catenin regulation,' J. Korean Med. Sci. 2004, 19, 275-282. (64) Dahmen, R. P.; Koch, A.; Denkhaus, D.; Tonn, J. C.; Sorensen, N.; Berthold, F.; Behrens, J.; Birchmeier, W.; Wiestler, O. D.; Pietsch, T. 'Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas,' Cancer Res. 2001, 61, 7039-7043. (65) Gu, J.; Wu, X.; Dong, Q.; Romeo, M. J.; Lin, X.; Gutkind, J. S.; Berman, D. M. 'A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans,' Cancer 2006, 106, 2716-2724. (66) Engvall, E.; Perlmann, P. 'Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G,' Immunoch. 1971, 8, 871-874. (67) Porstmann, T.; Kiessig, S. T. 'Enzyme immunoassay techniques. An overview,' J. Immunol. Methods 1992, 150, 5-21. (68) Paulie, S.; Perlmann, H.; Perlmann, P. In eLS; John Wiley Sons, Ltd, 2001. (69) Hornbeck, P. In Current Protocols in Immunology; John Wiley Sons, Inc., 2001. (70) Wang, J.; Li, H.; Shelver, W.; Wang, Z.; Li, Q.; Li, J.; Xu, T. 'Development of a monoclonal antibody-based, congener-specific and solvent-tolerable direct enzyme-linked immunosorbent assay for the detection of 2,2',4,4'-tetrabromodiphenyl ether in environmental samples,' Anal. Bioanal. Chem. 2011, 401, 2249-2258. (71) Sano, T.; Smith, C. L.; Cantor, C. R. 'Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates,' Science 1992, 258, 120-122. (72) Adler, M.; Wacker, R.; Niemeyer, C. M. 'A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins,' Biochem. Biophys. Res. Commun. 2003, 308, 240-250. (73) Kazane, S. A.; Sok, D.; Cho, E. H.; Uson, M. L.; Kuhn, P.; Schultz, P. G.; Smider, V. V. 'Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR,' Proc. Natl. Acad. Sci. 2012, 109, 3731-3736. (74) Schweitzer, B.; Wiltshire, S.; Lambert, J.; O'Malley, S.; Kukanskis, K.; Zhu, Z.; Kingsmore, S. F.; Lizardi, P. M.; Ward, D. C. 'Immunoassays with rolling circle DNA amplification: A versatile platform for ultrasensitive antigen detection,' Proc. Natl. Acad. Sci. 2000, 97, 10113-10119. (75) Niemeyer, C. M.; Adler, M.; Wacker, R. 'Immuno-PCR: high sensitivity detection of proteins by nucleic acid amplification,' Trends Biotechnol. 2005, 23, 208-216. (76) Zhou, H.; Fisher, R. J.; Papas, T. S. 'Universal immuno-PCR for ultra-sensitive target protein detection,' Nucleic Acids Res. 1993, 21, 6038-6039. (77) Tsujii, H.; Okamoto, Y.; Nakano, H.; Watanabe, K.; Naraki, T. 'Application of immuno-PCR assay to detect an ultra-low level plasma protein, pivka-II,' Int. Hepatol. Commun. 1995, 3, 154-154. (78) Zhang, Z.; Irie, R. F.; Chi, D. D.; Hoon, D. S. 'Cellular immuno-PCR. Detection of a carbohydrate tumor marker,' Am. J. Pathol. 1998, 152, 1427-1432. (79) Saito, K.; Kobayashi, D.; Sasaki, M.; Araake, H.; Kida, T.; Yagihashi, A.; Yajima, T.; Kameshima, H.; Watanabe, N. 'Detection of human serum tumor necrosis factor-alpha in healthy donors, using a highly sensitive immuno-PCR assay,' Clin. Chem. 1999, 45, 665-669. (80) Ren, J.; Chen, Z.; Juan, S. J.; Yong, X. Y.; Pan, B. R.; Fan, D. M. 'Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique,' Cancer 2000, 88, 280-285. (81) Sims, P. W.; Vasser, M.; Wong, W. L.; Williams, P. M.; Meng, Y. G. 'Immunopolymerase chain reaction using real-time polymerase chain reaction for detection,' Anal. Biochem. 2000, 281, 230-232. (82) Ren, J.; Ge, L.; Li, Y.; Bai, J.; Liu, W. C.; Si, X. M. 'Detection of circulating CEA molecules in human sera and leukopheresis of peripheral blood stem cells with E. coli expressed bispecific CEAScFv-streptavidin fusion protein-based immuno-PCR technique,' Ann. N. Y. Acad. Sci. 2001, 945, 116-118. (83) Masuda, M.; Morimoto, T.; De Haas, M.; Nishimura, N.; Nakamoto, K.; Okuda, K.; Komiyama, Y.; Ogawa, R.; Takahashi, H. 'Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis,' J. Rheumatol. 2003, 30, 1911-1917. (84) Nam, J.-M.; Thaxton, C. S.; Mirkin, C. A. 'Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins,' Science 2003, 301, 1884-1886. (85) Niemeyer, C. M.; Wacker, R.; Adler, M. 'Combination of DNA-directed immobilization and immuno-PCR: very sensitive antigen detection by means of self-assembled DNA–protein conjugates,' Nucleic Acids Res. 2003, 31, e90. (86) Nam, J. M.; Thaxton, C. S.; Mirkin, C. A. 'Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins,' Science (New York, N.Y.) 2003, 301, 1884-1886. (87) Mullis, K.; Faloona, F.; Scharf, S.; Saiki, R.; Horn, G.; Erlich, H. 'Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction,' Cold Spring Harb. Symp. Quant. Biol. 1986, 51 Pt 1, 263-273. (88) Craw, P.; Balachandran, W. 'Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review,' Lab Chip 2012, 12, 2469-2486. (89) Compton, J. 'Nucleic acid sequence-based amplification,' Nature 1991, 350, 91-92. (90) Walker, G. T.; Fraiser, M. S.; Schram, J. L.; Little, M. C.; Nadeau, J. G.; Malinowski, D. P. 'Strand displacement amplification--an isothermal, in vitro DNA amplification technique,' Nucleic Acids Res. 1992, 20, 1691-1696. (91) Demidov, V. V. 'Rolling-circle amplification in DNA diagnostics: the power of simplicity,' Expert Rev. Mol. Diagn. 2002, 2, 542-548. (92) Tan, E.; Erwin, B.; Dames, S.; Voelkerding, K.; Niemz, A. 'Isothermal DNA amplification with gold nanosphere-based visual colorimetric readout for herpes simplex virus detection,' Clin. Chem. 2007, 53, 2017-2020. (93) Vincent, M.; Xu, Y.; Kong, H. 'Helicase-dependent isothermal DNA amplification,' EMBO Rep. 2004, 5, 795-800. (94) Notomi, T.; Okayama, H.; Masubuchi, H.; Yonekawa, T.; Watanabe, K.; Amino, N.; Hase, T. 'Loop-mediated isothermal amplification of DNA,' Nucleic Acids Res. 2000, 28, E63. (95) Ness, J. V.; Ness, L. K. V.; Galas, D. J. 'Isothermal reactions for the amplification of oligonucleotides,' Proc. Natl. Acad. Sci. 2003, 100, 4504-4509. (96) Tan, E.; Wong, J.; Nguyen, D.; Zhang, Y.; Erwin, B.; Van Ness, L. K.; Baker, S. M.; Galas, D. J.; Niemz, A. 'Isothermal DNA amplification coupled with DNA nanosphere-based colorimetric detection,' Anal. Chem. 2005, 77, 7984-7992. (97) Liu, Y. Q.; Zhang, M.; Yin, B. C.; Ye, B. C. 'Attomolar ultrasensitive microRNA detection by DNA-scaffolded silver-nanocluster probe based on isothermal amplification,' Anal. Chem. 2012, 84, 5165-5169. (98) Qian, J.; Ferguson, T. M.; Shinde, D. N.; Ramírez-Borrero, A. J.; Hintze, A.; Adami, C.; Niemz, A. 'Sequence dependence of isothermal DNA amplification via EXPAR,' Nucleic Acids Res. 2012, e87. (99) Wang, G. L.; Zhang, C. Y. 'Sensitive detection of microRNAs with hairpin probe-based circular exponential amplification assay,' Anal. Chem. 2012, 84, 7037-7042. (100) Zhang, Z. Z.; Zhang, C. Y. 'Highly sensitive detection of protein with aptamer-based target-triggering two-stage amplification,' Anal. Chem. 2012, 84, 1623-1629. (101) Yan, Y.; Zhao, D.; Yuan, T.; Hu, J.; Zhang, D.; Cheng, W.; Zhang, W.; Ding, S. 'A simple and highly sensitive electrochemical biosensor for microRNA detection using target-assisted isothermal exponential amplification reaction,' Electroanalysis 2013, 25, 2354-2359. (102) Ma, F.; Yang, Y.; Zhang, C. Y. 'Ultrasensitive detection of transcription factors using transcription-mediated isothermally exponential amplification-induced chemiluminescence,' Anal. Chem. 2014, 86, 6006-6011. (103) Nie, J.; Zhang, D. W.; Zhang, F. T.; Yuan, F.; Zhou, Y. L.; Zhang, X. X. 'Reporter-triggered isothermal exponential amplification strategy in ultrasensitive homogeneous label-free electrochemical nucleic acid biosensing,' Chem. Commun. 2014, 50, 6211-6213. (104) Wang, K.; Zhang, K.; Lv, Z.; Zhu, X.; Zhu, L.; Zhou, F. 'Ultrasensitive detection of microRNA with isothermal amplification and a time-resolved fluorescence sensor,' Biosens. Bioelectron. 2014, 57, 91-95. (105) Xie, S.; Chai, Y.; Yuan, Y.; Bai, L.; Yuan, R. 'A novel electrochemical aptasensor for highly sensitive detection of thrombin based on the autonomous assembly of hemin/G-quadruplex horseradish peroxidase-mimicking DNAzyme nanowires,' Anal. Chim. Acta 2014, 832, 51-57. (106) Yu, Y.; Chen, Z.; Shi, L.; Yang, F.; Pan, J.; Zhang, B.; Sun, D. 'Ultrasensitive electrochemical detection of microRNA based on an arched probe mediated isothermal exponential amplification,' Anal. Chem. 2014, 86, 8200-8205. (107) Jia, H.; Li, Z.; Liu, C.; Cheng, Y. 'Ultrasensitive detection of microRNAs by exponential isothermal amplification,' Angew. Chem.-Int. Edit. 2010, 49, 5498-5501. (108) Watanabe, M.; Igai, K.; Matsuoka, K.; Miyagawa, A.; Watanabe, T.; Yanoshita, R.; Samejima, Y.; Terunuma, D.; Natori, Y.; Nishikawa, K. 'Structural analysis of the interaction between shiga toxin B subunits and linear polymers bearing clustered globotriose residues,' Infect. Immun. 2006, 74, 1984-1988. (109) Pelat, T.; Thullier, P. 'Non-human primate immune libraries combined with germline humanization: An (almost) new, and powerful approach for the isolation of therapeutic antibodies,' mAbs 2009, 1, 377-381. (110) Zhang, W.; Shi, Y.; Qi, J.; Gao, F.; Li, Q.; Fan, Z.; Yan, J.; Gao, G. F. 'Molecular basis of the receptor binding specificity switch of the hemagglutinins from both the 1918 and 2009 pandemic influenza A viruses by a D225G substitution,' J. Virol. 2013, 87, 5949-5958. (111) Martinez-Barricarte, R.; Heurich, M.; Lopez-Perrote, A.; Tortajada, A.; Pinto, S.; Lopez-Trascasa, M.; Sanchez-Corral, P.; Morgan, B. P.; Llorca, O.; Harris, C. L.; Rodriguez de Cordoba, S. 'The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome,' Mol. Immunol. 2015, 66, 263-273. (112) Vernet, T.; Choulier, L.; Nomine, Y.; Bellard, L.; Baltzinger, M.; Trave, G.; Altschuh, D. 'Spot peptide arrays and SPR measurements: throughput and quantification in antibody selectivity studies,' J. Mol. Recognit. 2015. (113) Xiang, Y.; Lu, Y. 'Using personal glucose meters and functional DNA sensors to quantify a variety of analytical targets,' Nat. Chem. 2011, 3, 697-703. (114) Pereira, M.; Lai, E. P. C. 'Capillary electrophoresis for the characterization of quantum dots after non-selective or selective bioconjugation with antibodies for immunoassay,' J. Nanobiotechnol. 2008, 6, 10-10. (115) Du, R.; Winarsih, I.; Ho, B.; Ding, J. L. 'Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobin,' Am. J. Clin. Exp. Immunol. 2012, 1, 33-48. (116) Pandey, J.; Ganesan, K.; Jain, R. K. 'Variations in T-RFLP profiles with differing chemistries of fluorescent dyes used for labeling the PCR primers,' J. Microbiol. Methods 2007, 68, 633-638. (117) Yu, S. L.; Tang, Y. Q.; Li, Y.; Zhang, H.; Wu, X. L. 'Gradient decrement of annealing time can improve PCR with fluorescent-labeled primers,' J. Biosci. Bioeng. 2010, 110, 500-504. (118) Suzuki, M. T.; Giovannoni, S. J. 'Bias caused by template annealing in the amplification of mixtures of 16S rRNA genes by PCR,' Appl. Environ. Microbiol. 1996, 62, 625-630. (119) Wood, W. G. ''Matrix effects' in immunoassays,' Scand. J. Clin. Lab. Invest. Suppl. 1991, 205, 105-112. (120) Martins, T. B.; Pasi, B. M.; Litwin, C. M.; Hill, H. R. 'Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum,' Clin. Diagn. Lab. Immunol. 2004, 11, 325-329. (121) Tate, J.; Ward, G. 'Interferences in immunoassay,' Clin. Biochem. Rev. 2004, 25, 105-120. (122) Phillips, D. J.; League, S. C.; Weinstein, P.; Hooper, W. C. 'Interference in microsphere flow cytometric multiplexed immunoassays for human cytokine estimation,' Cytokine 2006, 36, 180-188. (123) De Jager, W.; Bourcier, K.; Rijkers, G. T.; Prakken, B. J.; Seyfert-Margolis, V. 'Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays,' BMC Immunol. 2009, 10, 52-52. (124) Rosenberg-Hasson, Y.; Hansmann, L.; Liedtke, M.; Herschmann, I.; Maecker, H. T. 'Effects of serum and plasma matrices on multiplex immunoassays,' Immunol. Res. 2014, 58, 224-233. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/53173 | - |
| dc.description.abstract | 根據衛生福利部統計，近年來肺癌的死亡率節節上升，成為癌症死因死亡率之首；而癌症指標分子(tumor marker)的檢測則已成為肺癌治療或預後評估的重要一環。RGS11是G蛋白下游訊息路徑的調節因子，先前研究指出RGS11與肺癌轉移有關，是個與肺癌相關的蛋白；然而由於其在血液中的濃度極低(pg/mL左右)，無法使用市售的酵素連結免疫分析(Enzyme-linked immunosorbent assay, ELISA)套組分析監測。 本研究以修飾有抗體之磁珠為基礎，結合三明治免疫法(sandwich immunoassay)以及核酸等溫型指數放大技術 (isothermal exponential amplification reaction)發展出一套快速偵測且具高靈敏度的蛋白質分析平台，對肺癌相關蛋白RGS11進行檢測。在實驗步驟方面，將anti-RGS11 antibody藉由EDC/NHS反應連結到磁珠上，形成抗體修飾磁珠(MB-Ab)，接著加入已知濃度的His-tag RGS11以及血清中未知濃度的RGS11，使兩者競爭MB-Ab上anti-RGS11 antibody的接合位；最後，加入接有一段核酸引子的anti-His antibody (Ab-P)，使反應溶液內生成三明治免疫複合物，而抗體上的核酸引子可在短時間內進行等溫型的指數放大，形成許多雙股DNA產物；最後加入對雙股DNA有專一性的螢光染劑SYBR® Green，即可測得螢光訊號，而螢光訊號強度與血清中RGS11的量成反比關係，可做為評估血清中RGS11的依據。本實驗的設計優點為只需少量(20 μL)的樣品體積，即可在短時間 (1.5 hr)內完成偵測，且靈敏度高，偵測極限約為150 fg/mL。另外，本實驗可偵測兩倍稀釋之血清中，額外加入的RGS11，且回復率(Recovery rate)在90%以上。從上述結果我們認為本偵測平台在肺癌檢測方面具有運用潛力。 | zh_TW |
| dc.description.abstract | Lung cancer accounts for the primary cause of cancer-associated mortality worldwide, making the identification of reliable lung cancer biomarkers a pressing need for early diagnosis and prognosis. RGS11, a regulator of G-protein signaling, represents as a lung cancer biomarker, plays an important role in the cancer-related metastasis. However trace level of the RGS11 (~ pg/mL) in serum sample makes it a challenge for the quantification using currently available ELISA kits. It thus is our aim to develop a rapid and sensitive platform for the detection of RGS11 based on a sandwich immunoassay coupled with isothermal exponential amplification strategy. Our study was initiated with the functionalization of the magnetic beads with anti-RGS11 antibodies (MB-Ab) via EDC/NHS activation. Taking advantage of MB-Ab, it served as a sensing probe for the competitive immuno-recognitions between known concentration of His-tag RGS11, and unknown concentration of target RGS11 in serum. The reporter anti-His antibodies, modified with primers that induced an isothermal exponential amplification reaction, were subsequently introduced to reaction mixture leading to formation of immunosandwich complexs. The exponentially amplified DNA duplex intercalated with SYBR green was designated as signal output for the assessment of RGS11, in an inversely proportional relationship. The sensing platform demonstrated the excellent performance on the determination of RGS11 with exceptional detection limit of 150 fg/mL, along with minimal sample volume (20 μL), and reaction time 1.5 hr required. In addition, we challenged the sensing platform for the detection of spiked-RGS11 in 2x diluted serum samples, and acceptable recovery rate (higher than 90%) was observed . It is suggested that this sensing platform holds a potential in the biomedical application for screening lung cancer. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T16:48:53Z (GMT). No. of bitstreams: 1 ntu-104-R02b22028-1.pdf: 4289468 bytes, checksum: b209c9bd37d7b0b769536b10a34f5f42 (MD5) Previous issue date: 2015 | en |
| dc.description.tableofcontents | 1. 緒論................................................................. 1 1.1 肺癌及現行的肺癌篩檢方式 ................................................1 1.2 Regulators of G protein signaling protein (RGS protein).............3 1.2.1 G protein與RGS protein之交互作用.....................................3 1.2.2 RGS protein與癌症之關聯性............................................4 1.3 酵素連結免疫分析法 (Enzyme-linked immunosorbent assay, ELISA)...........7 1.3.1 直接型酵素連結免疫分析法 (Direct ELISA)................................7 1.3.2 間接型酵素連結免疫分析法 (Indirect ELISA)..............................8 1.3.3 三明治酵素連結免疫分析法 (Sandwich ELISA)............................. 9 1.3.4 競爭型酵素連結免疫分分析法 (Competitive ELISA).........................10 1.4 核酸連結免疫分析法......................................................12 1.5 等溫核酸放大法.........................................................15 1.5.1 等溫指數型放大法 (Exponential amplification reaction, EXPAR).........16 1.6 分子交互作用分析.......................................................18 1.7 研究動機.............................................................20 2. 材料與方法.............................................................21 2.1 材料.................................................................21 2.1.1 DNA序列............................................................21 2.1.2 實驗藥品及材料.......................................................21 2.1.3 緩衝溶液............................................................24 2.2 儀器.................................................................25 2.3 方法.................................................................27 2.3.1 聚丙醯胺膠體電泳法 (Polyacrylamide gel electrophoresis, PAGE)........27 2.3.2 墨跡實驗法 (Dot blot)...............................................27 2.3.3 核酸恆溫指數放大反應 (Exponential amplification reaction).............28 2.3.4 引子修飾抗體(Ab-P)之連結、分離、鑑定以及定量.............................29 2.3.5 引子修飾抗體(Ab-P)與肺癌標記蛋白His-tag RGS11交互分析................... 31 2.3.6 抗體修飾磁珠(MB-Ab)的兩次連結、定量以及活性測定...........................32 2.3.7 競爭型三明治免疫法與核酸等溫指數型放大(全反應實驗).........................34 2.3.8 回收率測試 (Recovery rate)..........................................35 2.3.8 使用Human RGS11 ELISA kit 測試血清及肺積水樣品........................35 2.3.9 本研究之偵檢平台測試血清及肺積水樣品....................................36 3. 實驗結果..............................................................37 3.1 實驗設計.............................................................37 3.2 EXPAR實驗條件優化.....................................................39 3.2.1 反應溶液...........................................................39 3.2.2 反應時間...........................................................42 3.2.3 EXPAR反應之偵測極限測定..............................................46 3.3 引子修飾抗體 (Ab-P)...................................................47 3.3.1 定性分析...........................................................47 3.3.2 膠體過濾純化以及定量.................................................48 3.3.3 活性分析:墨跡實驗法以及分子交互作用分析系統..............................52 3.3.4 Ab-P之EXPAR最佳反應時間以及偵測極限測定 ...............................58 3.4 抗體修飾磁珠 (MB-Ab)..................................................63 3.4.1 MB-Ab兩次合成後的定量分析............................................63 3.4.2 MB-Ab辨識RGS11的能力分析............................................ 67 3.5 全流程反應...........................................................68 3.5.1 參數條件優化 .......................................................68 3.5.2 全反應測試.........................................................71 3.5.3 回收率測試.........................................................72 3.6 真實樣品測試.........................................................74 3.6.1 血清樣品測試 .......................................................74 3.6.1 肺積水樣品測試......................................................78 4. 討論與結論............................................................80 5. 參考文獻.............................................................83 | |
| dc.language.iso | zh-TW | |
| dc.subject | RGS11 | zh_TW |
| dc.subject | 等溫型的指數放大 | zh_TW |
| dc.subject | 酵素連結免疫分析法 | zh_TW |
| dc.subject | ELISA | en |
| dc.subject | isothermal exponential amplification reaction | en |
| dc.subject | RGS11 | en |
| dc.title | 結合三明治免疫法及等溫型指數放大法開發快速偵檢癌症標記蛋白之分析平台 | zh_TW |
| dc.title | Development of a Rapid and Sensitive Immuno Sensing Platform for a Potential Cacer Biomarker RGS11: Integration of Sandwich Immunoassay and Isothermal Exponential Amplification Reaction | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 103-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 李世仁,陳俊顯,施能耀,吳立真,朱俐潔 | |
| dc.subject.keyword | 酵素連結免疫分析法,等溫型的指數放大,RGS11, | zh_TW |
| dc.subject.keyword | ELISA,isothermal exponential amplification reaction,RGS11, | en |
| dc.relation.page | 98 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2015-08-07 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 生化科技學系 | zh_TW |
| 顯示於系所單位： | 生化科技學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-104-1.pdf 未授權公開取用 | 4.19 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。